Sarcoidosis decisions — 2025

The Board remands the claim for service connection for sarcoidosis as new and relevant evidence has been received since the previous denial.

The Board remands the claims for service connection for cardiac and pulmonary sarcoidosis and obstructive sleep apnea due to a pre-decisional duty to assist error, requiring additional development.

The Board remands the claims for a disability rating greater than 10 percent for left ankle fracture with dislocation with arthritis and an initial, compensable disability rating for sarcoidosis from August 20, 2024, through February 13, 2025.

The Board remands the issue of entitlement to service connection for sarcoidosis as additional development is necessary.

The Board dismissed the veteran's appeals for service connection for major depressive disorder, tinnitus, sleep apnea, and a gastrointestinal disability due to untimeliness of the VA Form 10182. The appeal for service connection for sarcoidosis was denied based on the lack of evidence supporting a current disability.

The Board remands the issues of entitlement to revision of prior rating decisions on grounds of clear and unmistakable error (CUE) for further development.

The Board denied the Veteran's claim for service connection for sarcoidosis on a direct basis, finding that the evidence does not support a causal relationship between the Veteran's military service and his current condition.

The Board granted service connection for sarcoidosis, which manifested to a compensable degree within one year of the Veteran's separation from service. The claims for lupus and rheumatoid arthritis were remanded for further development.

The case is remanded to obtain a more thorough medical opinion regarding the Veteran's death and whether his service, including exposure to herbicides in Thailand, caused or triggered pulmonary sarcoidosis.

The veteran withdrew his appeal for service connection for shortness of breath before the Board made a decision.

The Board granted entitlement to Special Monthly Compensation (SMC) based on blindness in both eyes and remanded the issue of service connection for sarcoidosis due to a pre-decisional duty-to-assist error.

The Board denied service connection for abnormal heart chest pains, bronchitis, COPD, pleuritis, and sarcoidosis as there was no evidence of a current diagnosis. The Board also denied an initial rating in excess of 30 percent for PTSD with alcohol use disorder.

The Board granted service connection for hypertension, Parkinson's disease, cryptococcal infection, and sarcoidosis as secondary to the cryptococcal infection. COPD was also granted as secondary to both cryptococcal infection and Parkinson's disease.

The Board denied an effective date earlier than August 10, 2022, for the grant of a 60 percent rating for sarcoidosis, asthma, chronic bronchitis, and COPD.

The Board denied service connection for the cause of the Veteran's death, finding no evidence linking his death to any period of service or presumed exposure to contaminated water at Camp LeJeune.

The Board remands the claims for service connection for sarcoidosis and related conditions, as well as secondary service connection claims, due to an inadequate VA opinion regarding the etiology of the Veteran's sarcoidosis.

The Board remands the matter for a new medical examination to address the Veteran's claim for service connection for sarcoidosis, as the previous VA medical opinions did not adequately connect the Veteran's in-service symptoms with his current condition.

The Board granted service connection for sarcoidosis and necrobiotic granulomata under the PACT Act, but remanded claims for compensable evaluations of surgical scars.

The Board remands the claims for service connection for 12 respiratory conditions due to a need for additional medical evidence and examinations.

The Board denied service connection for sarcoidosis and interstitial lung disease, as the evidence did not support a finding that these conditions were related to the Veteran's military service.